Skip to content

CROI: More on sexual transmission of HCV in HIV+ gay men and heterosexual women

CROI: Liver fibrosis and noninvasive monitoring tools in HIV/HCV coinfected patients

CROI: Rapid response predicts success in HIV/HCV coinfected patients

CROI: Study fuels debate on role of GB virus C in HIV disease

Experimental HCV protease inhibitor to receive fast track approval

Hepatitis B genotype linked to degree of liver damage in HIV-positive patients

Tenofovir works as well for HBV in coinfected with 3TC resistance as 3TC/tenofovir in those without 3TC resistance

ALT levels may not give true picture of liver disease in HIV/HCV coinfected, suggests study

Hepatitis C protease inhibitor does well in early clinical trial